Showing 661 - 680 results of 19,699 for search '(( 50 ((ng decrease) OR (nn decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 661

    Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

    Published 2017
    “…Uremic serum increased the intracellular expression of IL-6, IFN-γ, TLR7, TLR9, VDR, CYP27b1 and CYP24a1. Treatment with 25 or 1,25 vitamin D decreased IL-6 and TLR9. …”
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668

    Decreased innervation and decreased epidermal thickness in STZ diabetic rats. by Shoista Kambiz (740608)

    Published 2015
    “…<p>Decreased density PGP9.5-IR nerve fibers (<b>A</b>) and average epidermal thickness (<b>F</b>) was demonstrated in the plantar skin of diabetic animals 4, 6, and 8 weeks after induction of diabetes (black bars) when compared to control (white bar). …”
  9. 669
  10. 670

    Knockdown of NRP1 increases while knockdown of NRP2 decreases formation of Schwann cell clusters. by Kasper C. D. Roet (444802)

    Published 2014
    “…SCs are shown in grey (S100 labeling). MCs are not labeled. Valid cell clusters were outlined with a blue line. …”
  11. 671

    AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

    Published 2010
    “…<p>Representative images of BrdU immunostaining in the subgranular zone (SGZ) of the dentate gyrus performed on 1.5-mont-old (<b>A</b>) 3-month-old (<b>C</b>) and 12-month old (<b>D</b>) wild-type and FeCγ25 animals one day after the final BrdU injection (100 mg/kg). …”
  12. 672
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677
  18. 678
  19. 679

    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

    Published 2025
    “…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca<sup>2+</sup> concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”
  20. 680

    Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Mechanistically, recombinant human S100A9 protein was found to induce a decrease in intracellular Ca<sup>2+</sup> concentration, while AT-1 regulated the expression of tight junction proteins via modulation of the AMPK/mTOR signaling pathway. …”